← SynDRA
ALTINICLINE
SynDRA canonical compound SYN0004112 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | CHRNA4 | CHRNB2 |
|---|
| Mechanism of action | nicotinic receptor agonist |
|---|
All known targets
- CHRNA4
- CHRNB2
- CHRNA4-CHRNB2
Mechanisms of action (all sources)
- CHRNB2 AGONIST
- Neuronal acetylcholine receptor; alpha4/beta2 agonist
- CHRNA4 AGONIST
- nicotinic receptor agonist
- Modulator
Cross-references
Synonyms
- Altiniclina
- (-)-5-ethynylnicotine
- SIB-1508Y
- SIB-1765F
- SIB 1765F
- Pyridine, 3-ethynyl-5-(1-methyl-2-pyrrolidinyl)-, (E)-2-butenedioate (1:1)
- Pyridine, 3-ethynyl-5-(1-methyl-2-pyrrolidinyl)-, (2E)-2-butenedioate (1:1)
- C12H14N2.C4H4O4
- AC1O5WWQ
- SCHEMBL194945
- SCHEMBL3099334
- SIB 1508Y, fumarate, E-isomer
- LS-173698
- CHEMBL111580
- 3-ethynyl-5-(1-methylpyrrolidin-2-yl)pyridine
- 5-Ethynyl-3-(1-methyl-2-pyrrolidinyl)pyridine
- 5-Ethynyl Nicotine
- 3-ethynyl-5-(1-methyl-2-pyrrolidinyl)pyridine
- AC1L326X
- SCHEMBL1155706
- BDBM86544
- NUPUDYKEEJNZRG-UHFFFAOYSA-N
- CHEBI:125396
- NSC_6442277
- CAS_192231-16-6
- 3-ethynyl-5-(1-methylpyrrolidin-2-yl)-pyridine
- 3-(1-Methylpyrrolidine-2-yl)-5-ethynylpyridine
- A812432
- (-)-5-Ethynylnicotine
- RJ9V9V09VM
- 3-Ethynyl-5-[(2S)-1-methyl-2-pyrrolidinyl]pyridine
- 3-Ethynyl-5-((2S)-1-methyl-2-pyrrolidinyl)pyridine
- altiniclinum
- RefChem:1067823
- DTXCID601526912
- Altinicline [INN]
- 3-ethynyl-5-[(2S)-1-methylpyrrolidin-2-yl]pyridine
- Pyridine, 3-ethynyl-5-((2S)-1-methyl-2-pyrrolidinyl)-
- Pyridine, 3-ethynyl-5-[(2S)-1-methyl-2-pyrrolidinyl]-
Look up ALTINICLINE in the interactive SynDRA portal →